株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の血液銀行市場の分析:新興の検査、技術評価、検査装置レビュー、売上高予測(国別)、主要サプライヤーの戦略的プロファイル

2013 Analysis of the Global Blood Banking Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers

発行 Venture Planning Group 商品コード 262526
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。

Local License: 同一事業所内

Back to Top
世界の血液銀行市場の分析:新興の検査、技術評価、検査装置レビュー、売上高予測(国別)、主要サプライヤーの戦略的プロファイル 2013 Analysis of the Global Blood Banking Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers
出版日: ページ情報: 英文
概要

当レポートでは、世界の血液銀行市場について調査分析し、新興の検査技術と潜在的応用、検査装置、主要サプライヤーの売上高予測(国別)を提供し、戦略的プロファイルも含めて、概略以下の構成でお届けいたします。

第1章 ビジネス環境

第2章 市場構造

第3章 市場規模・成長率

第4章 主な血液型・分類・感染症スクリーニング検査

  • 血液型・分類検査
  • 感染症スクリーニング検査
    • AIDS
    • 肝炎
    • サイトメガロウイルス
    • 梅毒
    • 西ナイルウイルス
    • パルボウイルスB19
    • クロイツフェルト・ヤコブ病
    • マラリア
    • シャガス病
    • バベシア症
  • 病原体の減少
  • 白血球の減少

第5章 検査装置のレビュー

第6章 主な体外診断技術とその潜在的用途

  • 分子診断
    • 概要
    • NAT
  • モノクローナル抗体とポリクローナル抗体
  • イムノアッセイ(免疫測定法
    • 技術原理
    • 化学発光
    • EIA
    • RIA
    • 免疫沈降
    • アフィニティー(親和性)クロマトグラフィー
  • 微量滴定プレート
  • IT・自動化
  • レーザー
  • ロボット工学
  • 合成赤血球代替物
  • 遺伝子組み換え血液成分
    • アルブミン
    • 第VIII因子
    • α-2抗プラスミン因子
    • アンチトロンビンIII
    • 第IX因子
    • フォン・ヴィレブランド因子
    • フィブリノゲン
    • t-PA
  • 血液保存
  • 自己血輸血/冷凍保存

第7章 競合企業の評価

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • 富士レビオ
  • Hologic/Gen-Probe
  • Grifols
  • Immucor
  • Innogenetics
  • Ortho-Clinical Diagnostics
  • Orchid CellMark
  • Novartis Diagnostics
  • Proteome Sciences
  • Roche
  • Siemens
  • Tecan

図表

目次
Product Code: VPBB4161

This new 340-page report from Venture Planning Group provides analysis of the global blood banking market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. 

The report presents:

  • Estimated numbers of laboratories performing blood banking testing, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S.
  • Comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.
  • Review of current instrumentation technologies, and features of leading blood banking automated and semi-automated analyzers.
  • Assessments of molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing technologies and their potential applications for blood banking testing. 
  • Profiles of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. 

Contains: 340 pages and 11 tables.

Table of Contents

I. Business Environment

II. Market Structure

III. Market Size and Growth

IV. Major Blood Typing, Grouping and Infectious Disease Screening Tests

  • 1. Blood Typing and Grouping Tests
    • a. ABO
    • b. Antibody Panels
    • c. Antibody Screening
    • d. Antigen Typing
    • e. Antiglobulin Test
    • f. Crossmatch
    • g. HLA Typing
    • h. Rh
    • i. Other Blood Groups
  • 2. Infectious Disease Screening Tests
    • a. AIDS
      • Structure and Composition
      • Classification
      • Origin of AIDS
      • Animal Lentivirus Systems
      • Virus Receptors
      • HIV Infections in Humans
        • Pathogenesis & Pathology
        • Overview of Course of HIV Infection
      • CD4T Lymphocytes and Memory Cells
      • Monocytes and Macrophages
      • Lymphoid Organs
      • Neural Cells
      • Viral Coinfections
        • Clinical Findings
      • Plasma Viral Load
      • Pediactric AIDS
        • Neurologic Disease
        • Opportunistic Infections
        • Protozoa
        • Fungi
        • Bacteria
      • Viruses
      • Cancer
      • Immunity
      • Laboratory Diagnosis
        • Virus Isolation
        • Serology
        • Detection of Viral Nucleic Acid or Antigens
      • Epidemiology
        • Worldwide Spread of AIDS
        • United States
        • Routes of Transmission
      • Prevention, Treatment, And Control
        • Antiviral Drugs
        • Vaccines Against HIV
      • Transmission of HIV in Blood Products
      • HIV Transmission in Transplant and Artificial Insemination Recipients
      • Diagnostic Tests
      • Enzyme Immunoassay Interpretation
      • Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
      • Competition Assays
      • Western Blot Technique
      • Immuno-Fluorescence Assay (IFA)
      • Radioimmunoprecipitation
      • HIV-1/HIV-2 Combination Testing
      • Methods of HIV-Antigen Detection
      • Antigen Assays and Blood Screening
      • Urine Tests
      • DNA Probes
      • Overview
      • Quantitative Polymerase Chain Reaction
      • In Situ PCR
      • Needed Improvements
      • Viral Load/Drug Resistance Testing
      • Genotype and Phenotype Testing
      • Blood Banking Considerations
    • b. Hepatitis
      • Hepatitis A
      • Hepatitis B
        • Structure and Composition
        • Replication of Hepatitis B Virus
      • Hepatitis C
      • Hepatitis D (Delta Hepatitis)
      • Hepatitis E
      • Hepatitis G
      • Hepatitis Virus Infections In Humans
        • Pathology
      • Clinical Findings
      • Laboratory Features
        • Hepatitis A
        • Hepatitis B
        • Hepatitis C
        • Hepatitis D
        • Hepatitis E
      • Virus-Host Immune Reactions
      • Epidemiology
        • Hepatitis A
        • Hepatitis B
        • Hepatitis C
        • Hepatitis D (Delta Agent)
      • Vaccines and Drugs
    • c. Cytomegalovirus
      • Background
      • Chorioretinitis
      • Gastrointestinal
      • Central Nervous System Disease
      • Diagnostic Tests
      • Vaccines and Drugs
    • d. Syphilis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • e. West Nile Virus
      • Background
      • Clinical Syndromes
      • Diagnostic Tests
      • Vaccines and Drugs
    • f. Parvovirus B19
      • Microbiology
      • Epidemiology
      • Clinical Syndromes
        • Erythema Infectiosum Slapped (cheek)
        • Adult Polyarthropathy
        • Transient Aplastic Crisis
        • Transient Pancytopenia
        • Red Cell Aplasia in the Immunocompromised
        • Perinatal Infections
      • Diagnosis
      • Treatment
    • g. Creutzfeldt-Jakob's Disease
      • Background
      • Transmission
      • Diagnostic Tests
      • Major Commercial and Academic Players
        • Bayer
        • Disease Sciences/BioTec Global
        • Imperial College School of Medicine
        • Ortho-Clinical Diagnostics
        • Pall
        • ProMetic Life Sciences
        • Proteome Sciences/Idexx
        • Q-One Biotech
        • Serono
        • U.S. Agricultural Research Service
      • Drugs
      • Vaccines
    • h. Malaria
    • i. Chagas Disease
    • j. Babesiosis
  • 3. Pathogen Reduction
  • 4. Leukocyte Reduction
    • Background
    • Methods

V. Instrumentation Review: Operating characteristics, features and selling prices of leading automated and semiautomated analyzers manufactured by Abbott, Beckman Coulter/Danaher, Bio-Rad, BioMerieux, Gen-Probe/Hologic, Grifols, Immucor, Nanosphere, Ortho-Clinical Diagnostic, Roche, Sarstedt, Siemens, Tecan and other suppliers

VI. Major in Vitro Diagnostic Technologies And Their Potential Applications

  • 1. Molecular Diagnostics
    • a. Overview
    • b. NAT
  • 2. Monoclonal and Polyclonal Antibodies
  • 3. Immunoassays
    • a. Technological Principle
    • b. Chemiluminescence
    • c. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • EMIT
      • Electrochemical
    • d. Radioimmunoassays (RIA)
    • e. Immunoprecipitation
    • f. Affinity Chromatography
  • 4. Microtitration Plates
  • 5. IT and Automation
  • 6. Lasers
  • 7. Robotics
  • 8. Synthetic Red Cell Substitutes
  • 9. Genetically Engineered Blood Components
    • a. Albumin
    • b. Factor VIII
    • c. Alpha-2 Antiplasmin
    • d. Antithrombin III
    • e. Factor IX
    • f. Von Willebrand's Factor
    • g. Fibrinogen
    • h. t-PA
  • 10. Blood Preservation
  • 11. Autologous Blood Transfusion/Freezing

VII. Competitive Assessments

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Hologic/Gen-Probe
  • Grifols
  • Immucor
  • Innogenetics
  • Ortho-Clinical Diagnostics
  • Orchid CellMark
  • Novartis Diagnostics
  • Proteome Sciences
  • Roche
  • Siemens
  • Tecan

List of Tables

  • Major Companies Developing or Marketing Blood Typing and Grouping Tests
  • Major Companies Developing or Marketing HLA Typing Tests
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Blood Bank Analyzers
  • Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country
  • Worldwide, All Market Segments, Total Blood Typing and Grouping Test Volume Forecast By Country
  • Worldwide, All Market Segments, Total Infectious Disease Screening Test Volume Forecast
  • Worldwide, All Market Segments, Total Blood Typing and Grouping Reagent Market Forecast By Country
  • Worldwide, All Market Segments, Total Infectious Disease Reagent Market Forecast By Country
Back to Top